Wordt geladen...
Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia
Current objectives regarding treatment of acute myeloid leukemia (AML) include achieving complete remission (CR) by clinicopathological criteria followed by interrogation for the presence of minimal/measurable residual disease (MRD) by molecular genetic and/or flow cytometric techniques. Although ad...
Bewaard in:
| Gepubliceerd in: | Blood |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Hematology
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7225688/ https://ncbi.nlm.nih.gov/pubmed/32232484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019004770 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|